We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Stem Cells in Drug Discovery

Article   Apr 04, 2017 | By Anna MacDonald, Editor for Technology Networks

 
Stem Cells in Drug Discovery

Anna Macdonald

Science Writer

 
 
 

RELATED ARTICLES

Gram Positive vs Gram Negative

Article

Being able to differentiate bacterial species is important for a host of reasons. Whilst molecular techniques can determine the specific species, even without getting into the molecular nitty gritty, there are phenotypic differences between groups of bacteria that can be used to differentiate them. One such useful classification – if a bacterium is Gram positive or Gram negative - is based on the structure of bacterial cell walls.

READ MORE

Therapeutic Gene Editing for Sickle Cell Disease

Article

Sickle cell disease is the most common inherited blood disorder in the US, affecting > 70,000 Americans. Christopher Vakulskas, Senior Staff Scientist, Integrated DNA Technologies discusses efforts to develop a sickle cell disease therapy using CRISPR gene editing.

READ MORE

Why Science Can’t Afford Mistakes When It Comes to Cell Line Authenticity

Article

Having strains and cell lines that have been checked and confirmed to be what it says on the tube is invaluable to scientific validity and integrity, saving untold time and money. We spoke to Mindy Goldsborough, Ph.D., Chief Science and Technology Officer, VP and General Manager, ATCC Cell Systems about the importance and challenges of maintaining authenticated cell lines for scientific research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE